Multiple Endocrine Neoplasia
📧 Sign up to get email alerts when something new happens for Multiple Endocrine Neoplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors [Phase 2, Phase 3]
This clinical trial update evaluates the accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT imaging for localizing parathyroid tu…
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Studies of Elevated Parathyroid Activity [Phase 2]
Phase 2 clinical trial updates on studies of elevated parathyroid activity completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors [Phase 2]
Phase II study of pertuzumab in combination with erlotinib for metastatic or unresectable neuroendocrine tumors was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Treatment of Zollinger-Ellison Syndrome With Prevacid [Phase 4]
Phase 4 trial update evaluating lansoprazole (Prevacid) for Zollinger-Ellison syndrome; results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-10-07Clinical Trial Update: High Dose Somatostatin Analogues in Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating high-dose somatostatin analogues in neuroendocrine tumors has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.